News Features Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too Michael O'Riordan December 18, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Conference News VEITH 2019 Endovascular Office-Based Labs: Balancing Upsides Against Potential for Abuse L.A. McKeown November 28, 2019
News Conference News PCR London Valves 2019 Signal of Impaired Sapien XT Durability in Midterm Follow-up Michael O'Riordan November 20, 2019
News Conference News AHA 2019 AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials Shelley Wood November 11, 2019
News Daily News CMS Confirms Substantial Cuts to Cardiac CT Reimbursement in 2020 Yael L. Maxwell November 08, 2019
News Daily News Sapien 3 Valve Approved in Europe for Low-Risk Patients Michael O'Riordan November 06, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2019 Todd Neale October 31, 2019
Podcast TCTMD Talking Points PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves October 25, 2019
News Conference News TCT 2019 Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences L.A. McKeown October 09, 2019
News Daily News PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’ Shelley Wood October 08, 2019
News Conference News TCT 2019 Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA Todd Neale October 04, 2019
News Conference News TCT 2019 TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 Yael L. Maxwell September 29, 2019
News Conference News TCT 2019 Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR Todd Neale September 29, 2019
Presentation TCT 2019 PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk Presenter: Suzanne Baron September 29, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Four: Costs and Quality of Life Take Center Stage Shelley Wood September 29, 2019
Presentation TCT 2019 PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis Presenter: Vinod Thourani September 28, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL Shelley Wood September 28, 2019